Schering-Plough Adds Levitra To Product Portfolio Through Deal With Bayer
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer abandons primary care market in U.S. and will cut 1,800 sales positions. Schering-Plough will take over marketing of Avelox and Cipro as well as Bayer's portion of Levitra co-promotion efforts.